Registered Private limited company (OÜ) Estonian Business Register

EEHyperpharm OÜ

Reg. no. 14669221 VAT no. — Registered 26.02.2019 NACE 46.38
Registered address Harju maakond, Tallinn, Kesklinna linnaosa, Narva mnt 7
92/100
Risk score
Low risk
2 risk signals
Share capital
2 500 EUR
Turnover
79 763 EUR
2025
Net profit
-5 441 EUR
2025
Employees
0
2025

About the company

The company Hyperpharm OÜ (reg. no. 14669221) was registered on 26.02.2019. Registered address: Harju maakond, Tallinn, Kesklinna linnaosa, Narva mnt 7. Main industry: Wholesale and retail trade. In 2025, revenue was 79 763 EUR and profit -5 441 EUR. Revenue change compared with 2024: +241,7%. Regmio risk score: 92 out of 100 — low risk.

Financials by year

YearTurnoverNet profitEmployees
202579 763 EUR -5 441 EUR0
202423 341 EUR 12 630 EUR0
2023— 0 EUR0
2022— 0 EUR0
2021— 0 EUR0
2020— 0 EUR0

Activity

46381 Muude toidukaupade hulgimüük

Frequently asked questions about Hyperpharm OÜ

When was Hyperpharm OÜ registered?

Hyperpharm OÜ was registered on 26.02.2019, registration number 14669221.

Is Hyperpharm OÜ active?

Yes, according to the register the company is active (not removed from the register).

What is the registered address of Hyperpharm OÜ?

Registered address: Harju maakond, Tallinn, Kesklinna linnaosa, Narva mnt 7.

Is Hyperpharm OÜ VAT registered?

No VAT number is listed in the register data.

What does Hyperpharm OÜ do?

Main industry: Wholesale and retail trade.

What is the turnover of Hyperpharm OÜ?

In 2025, revenue was 79 763 EUR.

Who manages and owns Hyperpharm OÜ?

The registers list 1 officers and 2 owners or beneficial owners. Names and shares are in the full profile.

Full profile available after login

Free account — 3 full profiles per month. Log in with an e-mail code, no password.

  • Board and authorised representatives 1
  • Owners and beneficial owners 2
  • Financial indicators 7
  • Tax and VAT
  • Legal events and restrictions
  • Timeline 18
Open full profile

Data from official public registers · updated 09.11.2026. Data sources and disclaimer